Marvell’s proposed acquisition of Lumentum is facing skepticism from merger-arbitrage specialists. A selloff in both stocks has left Lumentum trading well below the value of Marvell’s all-stock offer.
Bloomberg reports that merger-arbitrage specialists see the deal’s chances of closing as uncertain, citing skepticism about whether the companies can complete a transaction that would rank among the largest tech deals. The article does not identify the specialists.